Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 16:00
Avadel Pharmaceuticals Free Cash Flow
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2025 | 36.82M |
| June 30, 2025 | 5.907M |
| March 31, 2025 | -24.77M |
| December 31, 2024 | -46.24M |
| September 30, 2024 | -81.98M |
| June 30, 2024 | -112.78M |
| March 31, 2024 | -131.64M |
| December 31, 2023 | -132.17M |
| September 30, 2023 | -122.17M |
| June 30, 2023 | -89.10M |
| March 31, 2023 | -69.78M |
| December 31, 2022 | -73.59M |
| September 30, 2022 | -77.80M |
| June 30, 2022 | -92.76M |
| March 31, 2022 | -85.39M |
| December 31, 2021 | -74.79M |
| September 30, 2021 | -74.15M |
| June 30, 2021 | -65.26M |
| March 31, 2021 | -62.87M |
| December 31, 2020 | -51.07M |
| September 30, 2020 | -39.05M |
| June 30, 2020 | -34.79M |
| March 31, 2020 | -28.34M |
| December 31, 2019 | -37.94M |
| September 30, 2019 | -52.84M |
| Date | Value |
|---|---|
| June 30, 2019 | -64.93M |
| March 31, 2019 | -102.71M |
| December 31, 2018 | -99.52M |
| September 30, 2018 | -91.53M |
| June 30, 2018 | -129.59M |
| March 31, 2018 | -81.69M |
| December 31, 2017 | -38.66M |
| September 30, 2017 | -16.51M |
| June 30, 2017 | 35.67M |
| March 31, 2017 | 22.31M |
| December 31, 2016 | 17.24M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 16.21M |
| December 31, 2014 | -11.63M |
| September 30, 2014 | -13.45M |
| June 30, 2014 | -16.88M |
| March 31, 2014 | -17.03M |
| December 31, 2013 | -22.26M |
| September 30, 2013 | |
| June 30, 2013 |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Jazz Pharmaceuticals Plc | 1.508B |
| Perrigo Co. Plc | 119.30M |
| GH Research Plc | -52.46M |
| Cosmo NV | -29.99M |
| Alkermes Plc | 221.65M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 23.27M |
| Cash from Investing (Quarterly) | -8.788M |
| Cash from Financing (Quarterly) | 2.636M |